Composition for promoting healthy bone structure
AssigneeMetagenics, Inc.
InventorsKim C. Krumhar, Holly A. Johnson
Life of this patent
Estimating the term…
Abstract
A dietary supplement for benefitting human bone health includes a calcium source, a source of vitamin D activity, and an osteoblast stimulant. A preferred calcium source is microcrystalline hydroxyapatite, which also contains protein (mostly collagen), phosphorus, fat, and other minerals. A preferred source of vitamin D activity is cholecalciferol, and a preferred osteoblast stimulant is ipriflavone. In addition to these basic ingredients, the composition can further include various other minerals known to occur in bone, vitamin C, and glucosamine sulfate, all of which exert beneficial effects on growth and maintenance of healthy bone. A method for benefitting human bone health involves administering a daily regimen of the dietary supplement.
Claims30
A composition for benefitting human bone health comprising an admixture of:
- (a) an effective amount of microcrystalline hydroxyapatite;
- (b) an effective amount of a calcium source other than microcrystalline hydroxyapatite;
- (c) an effective amount of a source of vitamin D activity;
- and
- (d) an effective amount of ipriflavone;
- wherein the amount of vitamin D activity per gram of microcrystalline hydroxyapatite is less than 200 I.U. and the amount of ipriflavone per gram of microcrystalline hydroxyapatite is less than 200 mg.
A method for supplementing a diet for benefitting human bone health comprising administering at least one daily serving of a composition comprising an admixture of:
- (a) an effective amount of microcrystalline hydroxyapatite;
- (b) an effective amount of a calcium source other than microcrystalline hydroxyapatite;
- (c) an effective amount of a source of vitamin D activity;
- and
- (d) an effective amount of ipriflavone;
- wherein the amount of vitamin D activity per gram of microcrystalline hydroxyapatite is less than 200 I.U. and the amount of ipriflavone per gram of microcrystalline hydroxyapatite is less than 200 mg.
Dependencies are inferred from the claim text.